3-Ethynylaniline CAS 54060-30-9 Chiyero >99.0% (GC) Erlotinib Hydrochloride Intermediate
Wopanga komanso wogulitsa Erlotinib Hydrochloride Intermediates
Erlotinib Hydrochloride CAS 183319-69-9
3-Ethynylaniline CAS 54060-30-9
6,7-Bis(2-Methoxyethoxy)-3H-Quinazolin-4-imodzi CAS 179688-29-0
Please contact: alvin@ruifuchem.com
Dzina la Chemical | 3-Ethynylaniline |
Mawu ofanana ndi mawu | 3-Aminophenylacetylene |
Nambala ya CAS | 54060-30-9 |
Nambala ya CAT | RF-PI2241 |
Stock Status | Mu Stock, Kupanga Mphamvu 50MT/Mwezi |
Molecular Formula | C8H7N |
Kulemera kwa Maselo | 117.15 |
Zomverera | Simamva Kuwala, Kuwala |
Boiling Point | 120 ℃/20 mmHg |
Kusungunuka kwamadzi | Zosasungunuka m'madzi |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Yellow Yellow to Brown Liquid |
Kuyera / Kusanthula Njira | >99.0% (GC) |
Madzi ndi Karl Fischer | <0.50% |
Zotsalira pa Ignition | <0.20% |
Zonse Zonyansa | <1.00% |
Specific Gravity (20/20 ℃) | 1.041 ~ 1.048 |
Refractive Index n20/D | 1.614 ~ 1.6195 |
Infrared Spectrum | Zimagwirizana ndi Kapangidwe |
Proton NMR Spectrum | Zimagwirizana ndi Kapangidwe |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Mankhwala Wapakatikati;Erlotinib Hydrochloride Intermediate |
Phukusi: Botolo la fluorinated, 25kg / Drum, kapena malinga ndi zomwe kasitomala amafuna
Mkhalidwe Wosungira:Sungani muzitsulo zosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
3-Ethynylaniline, yomwe imadziwikanso kuti 3-Aminophenylacetylene (CAS: 54060-30-9) imagwiritsidwa ntchito ngati mankhwala apakatikati.3-Ethynylaniline ndi yapakatikati ya Erlotinib Hydrochloride (CAS: 183319-69-9).Erlotinib Hydrochloride ndi molekyu yaing'ono yotchedwa tyrosine kinase inhibitor yomwe imagwira ntchito mosinthika pa epidermal growth receptors, hydrochloride ya erlotinib, mankhwala omwe amapangidwa ndi maselo.Bungwe la US Food and Drug Administration (FDA) lavomereza erlotinib (Tarceva) yophatikizidwa ndi gemcitabine ngati njira yoyamba yothandizira khansa yapakhungu yam'deralo komanso metastatic.Amagwiritsidwa ntchito kwambiri ngati chithandizo chamzere wachiwiri kapena wachitatu wa khansa yam'mapapo yapamwamba kapena ya metstatic non-small cell mapapo (NSCLC) komanso ngati chithandizo cha khansa ya kapamba.Amagwiritsidwa ntchito ngati tyrosine inhibitor pamankhwala a NSCLC.Erlotinib Hydrochloride, quinazoline yotengedwa ndi molekyu yaing'ono ya epidermal growth receptor (EDGFR) tyrosine kinase, inavomerezedwa mu November, 2004, pofuna kuchiza khansa ya m'mapapo yapamwamba kapena ya metastatic yosakhala yaying'ono.